Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy

Journal of Surgical Oncology

Volumn 100, Issue 2, 2009, Pages 121-126

  Imai, Katsunori ^a   Beppu, Toru ^a   Nakayama, Yoshiharu ^a   Ishiko, Takatoshi ^a   Horino, K E I ^a   Komori, Hiroyuki ^a   Masuda, Toshiro ^a   Hayashi, Hiromitsu ^a   Okabe, Hirohisa ^a   Baba, Yoshihumi ^a,b   Watanabe, Masayuki ^a   Takamori, Hiroshi ^a   Awai, Kazuo ^a   Yamashita, Yasuyuki ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clinicopathological features; Contrast to noise ratio; Local ablation therapy; Poorly differentiated hepatocellular carcinoma; Small size

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS C ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER INVASION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 67749137527     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21302     Document Type: Article

References (38)

1. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750. (Pubitemid 29114292)
2. Taylor-Robinson SD, Foster GR, Arora S, et al.: Increase in primary liver cancer in the UK, 1979-1994. Lancet 1997;350: 1142-1143.
3. Bruix J: Treatment of hepatocellular carcinoma. Hepatology 1997;25:259-262.
4. Okuda K: Hepatocellular carcinoma. J Hepatol 2000;32:225-237.
5. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
6. Bruix J, Sherman M, Llovet JM, et al.: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.
7. Yamamoto J, Okada S, Shimada K, et al.: Treatment strategy for small hepatocellular carcinoma: Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34:707-713. (Pubitemid 32927994)
8. Poon RT, Fan ST, Tsang FH, et al.: Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective. Ann Surg 2002;235:466-486.
9. Vivarelli M, Guglielmi A, Ruzzenente A, et al.: Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004;240: 102-107. (Pubitemid 38808241)
10. Chen MS, Li JQ, Zheng Y, et al.: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243:321-328. (Pubitemid 43327762)
11. Shiina S, Teratani T, Obi S, et al.: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-130. (Pubitemid 41002049)
12. Curley SA, Marra P, Beaty K, et al.: Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004;239:450-458. (Pubitemid 38372760)
13. Komorizono Y, Oketani M, Sako K, et al.: Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003;97:1253-1262. (Pubitemid 36237312)
14. Imamura J, Tateishi R, Shiina S, et al.: Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 2008;103:3057-3062.
15. de Baere T, Risse O, Kuoch V, et al.: Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 2003;181:695-700. (Pubitemid 37021837)
16. Livraghi T, Lazzaroni S, Meloni F, et al.: Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005;92:856-858. (Pubitemid 40961405)
17. Llovet JM, Vilana R, Bru C, et al.: Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-1129. (Pubitemid 32378211)
18. Kotoh K, Enjoji M, Arimura E, et al.: Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma. World J Gastroenterol 2005;11:6828-6832. (Pubitemid 43092455)
19. Masuda T, Beppu T, Ishiko T, et al.: Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Surg 2008;15:589-595.
20. Ruzzenente A, Manzoni GD, Molfetta M, et al.: Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. World J Gastroenterol 2004;10:1137-1140. (Pubitemid 38559388)
21. Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. Tokyo: Kanehara & Co; 1997.
22. Ikeda K, Saitoh S, Tsubota A, et al.: Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25. (Pubitemid 23019276)
23. Tsai TJ, Chau GY, Lui WY, et al.: Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000;127:603-608.
24. Portolani N, Coniglio A, Ghidoni S, et al.: Early and late recurrence after liver resection for hepatocellular carcinoma: Prognostic and therapeutic implications. Ann Surg 2006;243: 229-235. (Pubitemid 43185442)
25. Fukuda S, Itamoto T, Nakahara H, et al.: Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 2005;52: 1163-1167. (Pubitemid 40942207)
26. Sasaki A, Kai S, Iwashita Y, et al.: Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005;103:299-306. (Pubitemid 40129289)
27. Okusaka T, Okada S, Ueno H, et al.: Satellite lesions in patients with small hepatocellular carcinoma with reference to clinico-pathologic features. Cancer 2002;95:1931-1937. (Pubitemid 35222173)
28. Belghiti J, Panis Y, Farges O, et al.: Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-117.
29. Oishi K, Itamoto T, Amano H, et al.: Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol 2007;95:311-316. (Pubitemid 46355507)
30. Todo S, Furukawa H: Living donor liver transplantation for adult patients with hepatocellular carcinoma: Experience in Japan. Ann Surg 2004;240:451-459; discussion 459-461. (Pubitemid 39121339)
31. Zavaglia C, De Carlis L, Alberti AB, et al.: Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005;100:2708-2716. (Pubitemid 43919639)
32. Shirabe K, Itoh S, Yoshizumi T, et al.: The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 2007; 95:235-240. (Pubitemid 46310016)
33. Hakamada K, Kimura N, Miura T, et al.: Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma. World J Gastroenterol 2008;14: 1370-1377.
34. Kobayashi M, Ikeda K, Kawamura Y, et al.: High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Cancer 2009;115:571-580.
35. Amano S, Ebara M, Yajima T, et al.: Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2003;18:273-279. (Pubitemid 36513156)
36. Imai Y, Murakami T, Yoshida S, et al.: Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading. Hepatology 2000;32:205-212. (Pubitemid 30614651)
37. Jang HJ, Kim TK, Burns PN, et al.: Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: Comparison with histologic differentiation. Radiology 2007;244:898-906. (Pubitemid 47292103)
38. Seo S, Hatano E, Higashi T, et al.: Fluorine-18 fluorodeoxy-glucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 2007;13:427-433.